NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

35 hedge funds and large institutions have $575K invested in Nymox Pharmaceutical Corp in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
$3K
Net Calls
Net Calls Change

Top Buyers

1
+$103K
2
+$27.2K
3
+$17.6K
4
Millennium Management
Millennium Management
New York
+$16K
5
BlackRock
BlackRock
New York
+$1.33K

Top Sellers

1
-$10.1K
2
-$8.12K
3
-$8.11K
4
PFGIA
Patriot Financial Group Insurance Agency
Massachusetts
-$6.43K
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.64K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$1.78K
28
$1.6K
29
$1.12K
30
$755
31
$292
32
$240
33
$128
34
–
35
–
36
–
37
–
38
–
1
2